These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 20177417)

  • 1. Myelin maintenance: axonal support required.
    Popko B
    Nat Neurosci; 2010 Mar; 13(3):275-7. PubMed ID: 20177417
    [No Abstract]   [Full Text] [Related]  

  • 2. Axonal prion protein is required for peripheral myelin maintenance.
    Bremer J; Baumann F; Tiberi C; Wessig C; Fischer H; Schwarz P; Steele AD; Toyka KV; Nave KA; Weis J; Aguzzi A
    Nat Neurosci; 2010 Mar; 13(3):310-8. PubMed ID: 20098419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axonal and neuronal degeneration in myelin diseases.
    Ohno N; Ikenaka K
    Neurosci Res; 2019 Feb; 139():48-57. PubMed ID: 30179642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisomes, myelination, and axonal integrity in the CNS.
    Baes M; Aubourg P
    Neuroscientist; 2009 Aug; 15(4):367-79. PubMed ID: 19666893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional metabolism of brain phospholipids.
    Ansell GB; Spanner S
    Int Rev Neurobiol; 1977; 20():1-29. PubMed ID: 22508
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism and functions of lipids in myelin.
    Schmitt S; Castelvetri LC; Simons M
    Biochim Biophys Acta; 2015 Aug; 1851(8):999-1005. PubMed ID: 25542507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spatiotemporal ablation of myelinating glia-specific neurofascin (Nfasc NF155) in mice reveals gradual loss of paranodal axoglial junctions and concomitant disorganization of axonal domains.
    Pillai AM; Thaxton C; Pribisko AL; Cheng JG; Dupree JL; Bhat MA
    J Neurosci Res; 2009 Jun; 87(8):1773-93. PubMed ID: 19185024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of CNS and PNS myelin proteins in the pathology of myelin disorders.
    Quarles RH
    J Neurol Sci; 2005 Feb; 228(2):187-9. PubMed ID: 15694201
    [No Abstract]   [Full Text] [Related]  

  • 9. Altered distribution, aggregation, and protease resistance of cellular prion protein following intracranial inoculation.
    Ward A; Hollister JR; Choi YP; Race B; Williams K; Shoup DW; Moore RA; Priola SA
    PLoS One; 2019; 14(7):e0219457. PubMed ID: 31291644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligodendrocytes are susceptible to apoptotic cell death induced by prion protein-derived peptides.
    Sponne I; Fifre A; Koziel V; Kriem B; Oster T; Olivier JL; Pillot T
    Glia; 2004 Jul; 47(1):1-8. PubMed ID: 15139007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular prion protein is implicated in the regulation of local Ca2+ movements in cerebellar granule neurons.
    Lazzari C; Peggion C; Stella R; Massimino ML; Lim D; Bertoli A; Sorgato MC
    J Neurochem; 2011 Mar; 116(5):881-90. PubMed ID: 21214552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6.
    Küffer A; Lakkaraju AK; Mogha A; Petersen SC; Airich K; Doucerain C; Marpakwar R; Bakirci P; Senatore A; Monnard A; Schiavi C; Nuvolone M; Grosshans B; Hornemann S; Bassilana F; Monk KR; Aguzzi A
    Nature; 2016 Aug; 536(7617):464-8. PubMed ID: 27501152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPI-anchor signal sequence influences PrPC sorting, shedding and signalling, and impacts on different pathomechanistic aspects of prion disease in mice.
    Puig B; Altmeppen HC; Linsenmeier L; Chakroun K; Wegwitz F; Piontek UK; Tatzelt J; Bate C; Magnus T; Glatzel M
    PLoS Pathog; 2019 Jan; 15(1):e1007520. PubMed ID: 30608982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosphingolipid synthesis in cerebellar Purkinje neurons: roles in myelin formation and axonal homeostasis.
    Watanabe S; Endo S; Oshima E; Hoshi T; Higashi H; Yamada K; Tohyama K; Yamashita T; Hirabayashi Y
    Glia; 2010 Aug; 58(10):1197-207. PubMed ID: 20544855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and regeneration of oligodendrocytes: therapeutic perspectives in demyelinating diseases].
    Dubois-Dalcq M
    Bull Mem Acad R Med Belg; 2005; 160(10-12):407-15; discussion 415-6. PubMed ID: 16768245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelination and the trophic support of long axons.
    Nave KA
    Nat Rev Neurosci; 2010 Apr; 11(4):275-83. PubMed ID: 20216548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin dynamics: protecting and shaping neuronal functions.
    Saab AS; Nave KA
    Curr Opin Neurobiol; 2017 Dec; 47():104-112. PubMed ID: 29065345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A glial investment of axons defrayed.
    Einheber S; Salzer JL
    Neuron; 2000 Dec; 28(3):627-8. PubMed ID: 11163251
    [No Abstract]   [Full Text] [Related]  

  • 19. The elusive role of the prion protein and the mechanism of toxicity in prion disease.
    Chiesa R
    PLoS Pathog; 2015 May; 11(5):e1004745. PubMed ID: 25951168
    [No Abstract]   [Full Text] [Related]  

  • 20. X-linked adrenoleukodystrophy enigma: how does the ALD peroxisomal transporter mutation affect CNS glia?
    Aubourg P; Dubois-Dalcq M
    Glia; 2000 Jan; 29(2):186-90. PubMed ID: 10625338
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.